Simulations Plus (SLP) Reports Prelim. Q4 Rev. of $24.1M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Simulations Plus Reports Preliminary Revenues for Fourth Quarter and Fiscal Year 2017
October 3, 2017 8:30 AM EDTCompany Reports Record Fourth-Quarter and Full-Year Revenues
LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical trials, today released preliminary revenues for its fiscal fourth quarter (4QFY17) and full fiscal year 2017 (FY2017) ended August 31, 2017.
Mr. John R. Kneisel, chief financial officer of Simulations Plus, stated: This quarter represents the first quarter where were reporting preliminary consolidated annual and fourth quarter revenues that include... More
